A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone

Clinical trial NCT00936403 · COMPLETED

Trial details

NCT number: NCT00936403
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Growth Hormone Disorder Growth Hormone Deficiency in Children

Start date: 2009-08-01
Primary completion: 2010-07-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.